SCHEMBL30709308

SCHEMBL30709308

c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2cc(-c3ccc(-c4cc(-c5cc(-c6ccccc6)nc(-c6ccccc6)c5)nc(-c5cc(-c6ccccc6)nc(-c6ccccc6)c5)c4)cc3)cc(-n3c4ccc(-c5ccccc5)cc4c4cc(-c5ccccc5)ccc43)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.41
MEN1 O00255 7/20 0.40
KMT2A Q03164 7/20 0.40
MCL1 Q07820 2/20 0.38
MYC P01106 1/20 0.36
CTRC Q99895 1/20 0.36
DHODH Q02127 1/20 0.36
MAPT P10636 5/20 0.36
ALDH1A1 P00352 4/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
POLB P06746 2/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
ALOX12 P18054 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ADORA1 P30542 2/20 0.35
ADORA3 P0DMS8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22126321 1.00 CYP19A1 (0.41) CYP19A1MEN1KMT2AMCL1MYC
SCHEMBL20771508 0.98 CYP19A1 (0.41) CYP19A1MEN1KMT2AMCL1MYC
SCHEMBL19928002 0.94 MEN1 (0.42) CYP19A1MEN1KMT2AMCL1MYC
SCHEMBL22126371 0.91 MEN1 (0.47) CYP19A1MEN1KMT2ACTRCDHODH
SCHEMBL19928003 0.91 MEN1 (0.40) CYP19A1MEN1KMT2AMCL1DHODH
SCHEMBL22126502 0.90 MEN1 (0.47) MEN1KMT2ACTRCMAPTALDH1A1
SCHEMBL15459662 0.90 TSPO (0.40) CYP19A1MEN1KMT2AMCL1DHODH
SCHEMBL17228152 0.90 TSPO (0.40) CYP19A1MEN1KMT2AMCL1DHODH
SCHEMBL22126436 0.90 MEN1 (0.47) MEN1KMT2ACTRCMAPTALDH1A1
SCHEMBL25899011 0.90 TSPO (0.40) CYP19A1MEN1KMT2AMCL1DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11849634-B2 Composition of matter for use in organic light- emitting diodes KYULUX, INC. (JP) 2023-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11849634-B2 Composition of matter for use in organic light- emitting diodes NDUFV3, NDUFV2, CRY2 CYP19A1 457/4885MEN1 2193/4885KMT2A 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.